Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
What is cancer, exactly? For the most part, experts agree. The National Cancer Institute defines cancer as “a disease...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
As we unpack our cardigans in anticipation of cooler weather here on the East Coast, we are taking a...
Guest post by Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH From November 7-9, 2022, Singapore will...
Washington, D.C., holds a special place in the history of the American Association for Cancer Research (AACR). In 1907,...
Editor’s Note: Raquel Castellanos is assistant director of Scientific Programs at the American Association for Cancer Research. She and...
In 2008, Robin Evans received a devastating diagnosis: stage 4 metastatic triple-negative breast cancer. This subtype of breast cancer,...
As the 15th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved...
Imagine your DNA as a shoelace. What would happen to the ends if there were no aglets there to...
Black Americans are more than twice as likely to die from prostate cancer than white Americans, highlighting a major...